These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2328491

  • 1. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD, Chen SR, Cuddy DP.
    Cancer Res; 1990 May 01; 50(9):2658-66. PubMed ID: 2328491
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
    Ross DD, Cuddy DP, Cohen N, Hensley DR.
    Cancer Chemother Pharmacol; 1992 May 01; 31(1):61-70. PubMed ID: 1458561
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 4. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1619-30. PubMed ID: 7980627
    [Abstract] [Full Text] [Related]

  • 5. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD, Akman SA, Joneckis CC, Yang E, Bachur NR.
    Cancer Res; 1984 Apr 18; 44(4):1530-5. PubMed ID: 6584206
    [Abstract] [Full Text] [Related]

  • 6. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ, Kufe DW.
    Cancer Res; 1982 Oct 01; 42(10):4050-3. PubMed ID: 6809309
    [Abstract] [Full Text] [Related]

  • 9. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 10. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1990 Dec 01; 25(6):418-24. PubMed ID: 2311169
    [Abstract] [Full Text] [Related]

  • 11. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL, Rustum YM.
    Cancer Res; 1985 May 01; 45(5):2002-7. PubMed ID: 3986756
    [Abstract] [Full Text] [Related]

  • 12. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov 01; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 13. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul 01; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 01; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 15. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb 01; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

  • 16. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB, Tong WP, Chou TC.
    Mol Pharmacol; 1991 Feb 01; 39(2):250-7. PubMed ID: 1705001
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
    Chan TC.
    Cancer Res; 1989 May 15; 49(10):2656-60. PubMed ID: 2713849
    [Abstract] [Full Text] [Related]

  • 18. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ.
    Mol Pharmacol; 1995 Aug 15; 48(2):305-15. PubMed ID: 7651364
    [Abstract] [Full Text] [Related]

  • 19. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Townsend AJ, Cheng YC.
    Mol Pharmacol; 1987 Sep 15; 32(3):330-9. PubMed ID: 2444869
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 15; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.